Glenmark PharmaceuticalsGLENMARK 
$20.09-0.02%24h
-0.02%24h
Global rank2511
Market cap$5.67B
Change 7d0.03%
YTD Performance97.60%
SP500 benchmarkOutperform
P/E1.91
P/S3.74
Revenue$1.52B
Earnings$44.94M
Dividend yield-
Main Sector
Healthcare
Glenmark Pharmaceuticals GLENMARK Operating Margins
Operating Margin in 2022: 0.13%
According to Glenmark Pharmaceuticals latest financial reports the company has an operating margin of 0.13%, an decrease of -13.24% to 2022. At the end of 2022 company had an operating margin of 0.15%.
Glenmark Pharmaceuticals Operating Margin from 2020 to 2024
-
Value:-
GLENMARK Operating Margin History by year
| Year | Operating Margin | Change |
|---|---|---|
| 2023 | 0.13% | -13.24% |
| 2022 | 0.15% | -4.82% |
| 2021 | 0.16% | 28.78% |
| 2020 | 0.12% | - |
View the highest operating margin companies 
